US-based biotechnology company Twist Bioscience closed a $61m series D round yesterday backed by biotechnology company Illumina, healthcare company WuXi PharmaTech and biotechnology holding firm Institut Mérieux.
Financial services conglomerate Fidelity Management and Research also contributed funds to the round. WuXi invested through its corporate venturing unit, WuXi Healthcare Ventures, while Institut Mérieux participated through its private equity arm, Mérieux Développement.
The corporates were joined by Arch Overage Fund, Cormorant Asset Management, Foresite Capital Management, Arch Venture Partners, Tao Invest,…
